Fetal Bovine Serum
Closed Solicitation Posted
- Solicitation number
- 75D30123Q77325
- Agency
-
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Fort Collins, Colorado 80521, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control (CDC) intends to issue a firm-fixed-price purchase order for Avantor® Seradigm, Premium Grade Fetal Bovine Serum (FBS), which requires temperature control for storage and delivery. The solicitation response date is set for 09/22/2023, with delivery of the product required on or before 09/29/2023. The contract will be awarded to the offeror whose offer is most advantageous to the government, with evaluation based on the lowest price technically acceptable.
List of Products and Services:
- Avantor® Seradigm, Premium Grade Fetal Bovine Serum (FBS)
- Temperature-controlled storage and delivery of the product.
Notice text
2 versions
Update #2 · Latest ·
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. Additionally, the Government will utilize simplified acquisition procedures in accordance with FAR Part 13.
**See attached combined synopsis/solicitation**
**9/22/2023: See attached amendment extending the deadline for quotes to 9/26/2023 and adjusting language in combined synopsis/solcitation.**
Update #1 ·
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. Additionally, the Government will utilize simplified acquisition procedures in accordance with FAR Part 13.
**See attached combined synopsis/solicitation**
Files
| File | Type | Posted |
|---|---|---|
| Amendment 9.22.pdf | ||
| 75D30123Q77325 Combined Synopsis Solicitation.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Blood grouping serum | Medical Supply Chain | No set-aside | |
| Varicella virus vacci | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity